CDMO and filled syringe specialist Vetter has broken the ground for a new clinical site construction in the greater Chicago area that is expected to be ready for early clinical filling by the end of 2029. 

Portuguese fibre producer Altri SGPS S.A.has signed an agreement to acquire a majority interest in Swiss clean technology company AeoniQ to support the commercial-scale development of the first fully biodegradable cellulose-based filament designed to replace polyester and nylon.

In life sciences, breakthroughs are reshaping healthcare faster than ever. But true leadership means going beyond the lab – understanding the complex ecosystem where ­science, policy, and business collide. For those struggling to navigate this complexity, WU ­Vienna’s Executive MBA offers the insights and connections needed to stay ahead in an ­unpredictable industry.

As the global race for biosolutions intensifies, Europe is at a critical crossroads, and I am deeply concerned about the future of our continent’s biotech industry. While countries like China and the United States rapidly advance their biotech industries, Europe’s slow and not up-to-date regulatory system poses a significant risk to maintaining our leadership.